

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 7.83221754 |
| 2 | * positive regulation by organism of defense response of other organism involved in symbiotic interact | 7.83221754 |
| 3 | * modulation by symbiont of host immune response (GO:0052553) | 7.83221754 |
| 4 | * positive regulation by symbiont of host defense response (GO:0052509) | 7.83221754 |
| 5 | * modulation by symbiont of host defense response (GO:0052031) | 7.83221754 |
| 6 | * modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 7.83221754 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 7.27287388 |
| 8 | * regulation of interferon-beta biosynthetic process (GO:0045357) | 5.91079007 |
| 9 | neutrophil activation involved in immune response (GO:0002283) | 5.81278345 |
| 10 | * macrophage activation involved in immune response (GO:0002281) | 5.29461978 |
| 11 | detection of other organism (GO:0098543) | 5.10523358 |
| 12 | response to peptidoglycan (GO:0032494) | 5.03664046 |
| 13 | * positive regulation of interferon-alpha production (GO:0032727) | 5.02126783 |
| 14 | * response to host immune response (GO:0052572) | 5.00640204 |
| 15 | * response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 5.00640204 |
| 16 | detection of external biotic stimulus (GO:0098581) | 4.81820498 |
| 17 | * regulation of interferon-alpha production (GO:0032647) | 4.73981846 |
| 18 | detection of bacterium (GO:0016045) | 4.53610309 |
| 19 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.50800377 |
| 20 | * positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.49501614 |
| 21 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.47928861 |
| 22 | respiratory burst (GO:0045730) | 4.46177275 |
| 23 | * response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.45604971 |
| 24 | * response to host (GO:0075136) | 4.45604971 |
| 25 | * response to host defenses (GO:0052200) | 4.45604971 |
| 26 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.39839633 |
| 27 | regulation of gamma-delta T cell activation (GO:0046643) | 4.34922390 |
| 28 | detection of biotic stimulus (GO:0009595) | 4.24596555 |
| 29 | positive regulation of mast cell activation (GO:0033005) | 4.18593255 |
| 30 | * microglial cell activation (GO:0001774) | 4.15005977 |
| 31 | I-kappaB phosphorylation (GO:0007252) | 4.12074374 |
| 32 | regulation of cholesterol storage (GO:0010885) | 4.08702309 |
| 33 | leukocyte aggregation (GO:0070486) | 4.08603405 |
| 34 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.05789645 |
| 35 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.99335440 |
| 36 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.97553001 |
| 37 | neutrophil activation (GO:0042119) | 3.95771293 |
| 38 | neutrophil mediated immunity (GO:0002446) | 3.92680838 |
| 39 | granulocyte activation (GO:0036230) | 3.89894935 |
| 40 | pinocytosis (GO:0006907) | 3.83794655 |
| 41 | * macrophage activation (GO:0042116) | 3.80317485 |
| 42 | * myeloid cell activation involved in immune response (GO:0002275) | 3.75633417 |
| 43 | positive regulation of antigen processing and presentation (GO:0002579) | 3.75544318 |
| 44 | negative regulation of T cell mediated immunity (GO:0002710) | 3.74913613 |
| 45 | * immunoglobulin mediated immune response (GO:0016064) | 3.74264801 |
| 46 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.69956913 |
| 47 | detection of molecule of bacterial origin (GO:0032490) | 3.69339842 |
| 48 | negative regulation of interleukin-17 production (GO:0032700) | 3.63281969 |
| 49 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.61442802 |
| 50 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.61349748 |
| 51 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.59985982 |
| 52 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.59427825 |
| 53 | regulation of mast cell activation (GO:0033003) | 3.56955291 |
| 54 | cellular extravasation (GO:0045123) | 3.54524816 |
| 55 | * positive regulation of interferon-beta production (GO:0032728) | 3.52298974 |
| 56 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.50434933 |
| 57 | regulation of mast cell degranulation (GO:0043304) | 3.48673060 |
| 58 | apoptotic cell clearance (GO:0043277) | 3.48582356 |
| 59 | response to interleukin-15 (GO:0070672) | 3.48479598 |
| 60 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.45933050 |
| 61 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.45920226 |
| 62 | regulation of mononuclear cell migration (GO:0071675) | 3.45363150 |
| 63 | defense response to protozoan (GO:0042832) | 3.44829024 |
| 64 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.42821535 |
| 65 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.41202360 |
| 66 | positive regulation of macrophage cytokine production (GO:0060907) | 3.40745772 |
| 67 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.40470240 |
| 68 | regulation of tolerance induction (GO:0002643) | 3.38950944 |
| 69 | regulation of T cell tolerance induction (GO:0002664) | 3.31922949 |
| 70 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.29412890 |
| 71 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.28147064 |
| 72 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.27550230 |
| 73 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.26702798 |
| 74 | lipoprotein transport (GO:0042953) | 3.24828251 |
| 75 | positive regulation of leukocyte degranulation (GO:0043302) | 3.24580829 |
| 76 | regulation of leukocyte degranulation (GO:0043300) | 3.24373408 |
| 77 | negative regulation of cell killing (GO:0031342) | 3.23829402 |
| 78 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.23829402 |
| 79 | negative regulation of mast cell activation (GO:0033004) | 3.21162586 |
| 80 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.20899022 |
| 81 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.18442173 |
| 82 | positive regulation of mast cell degranulation (GO:0043306) | 3.18442173 |
| 83 | B cell receptor signaling pathway (GO:0050853) | 3.15378844 |
| 84 | germinal center formation (GO:0002467) | 3.15377428 |
| 85 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.14916690 |
| 86 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.14525889 |
| 87 | cellular response to interleukin-15 (GO:0071350) | 3.12998458 |
| 88 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.11299859 |
| 89 | response to muramyl dipeptide (GO:0032495) | 3.09146050 |
| 90 | natural killer cell mediated immunity (GO:0002228) | 3.09123908 |
| 91 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.09123908 |
| 92 | regulation of antigen processing and presentation (GO:0002577) | 3.08350385 |
| 93 | response to protozoan (GO:0001562) | 3.07111217 |
| 94 | low-density lipoprotein particle clearance (GO:0034383) | 3.06460276 |
| 95 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.06389294 |
| 96 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.05008023 |
| 97 | dendritic cell migration (GO:0036336) | 3.04369994 |
| 98 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.03925563 |
| 99 | dendritic cell chemotaxis (GO:0002407) | 3.02044199 |
| 100 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.99277103 |
| 101 | regulation of macrophage cytokine production (GO:0010935) | 2.99126673 |
| 102 | * regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.98437105 |
| 103 | positive regulation of B cell differentiation (GO:0045579) | 2.96775540 |
| 104 | response to interferon-alpha (GO:0035455) | 2.96690814 |
| 105 | positive regulation of tolerance induction (GO:0002645) | 2.96672727 |
| 106 | cellular response to interferon-alpha (GO:0035457) | 2.96386507 |
| 107 | T cell migration (GO:0072678) | 2.95393558 |
| 108 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.94368206 |
| 109 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.94339737 |
| 110 | mannose metabolic process (GO:0006013) | 2.92296758 |
| 111 | leukocyte degranulation (GO:0043299) | 2.92175131 |
| 112 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.91928464 |
| 113 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.90757148 |
| 114 | neutrophil chemotaxis (GO:0030593) | 2.89922203 |
| 115 | response to lipoprotein particle (GO:0055094) | 2.89722318 |
| 116 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.89458627 |
| 117 | positive regulation of type 2 immune response (GO:0002830) | 2.88098264 |
| 118 | negative regulation of type 2 immune response (GO:0002829) | 2.87825341 |
| 119 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.87592807 |
| 120 | myeloid leukocyte mediated immunity (GO:0002444) | 2.87542848 |
| 121 | regulation of B cell differentiation (GO:0045577) | 2.86338554 |
| 122 | lymphocyte chemotaxis (GO:0048247) | 2.85898746 |
| 123 | superoxide anion generation (GO:0042554) | 2.82598709 |
| 124 | reactive oxygen species biosynthetic process (GO:1903409) | 2.82565307 |
| 125 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.81505625 |
| 126 | neutrophil migration (GO:1990266) | 2.81448196 |
| 127 | negative regulation of lipid storage (GO:0010888) | 2.81402241 |
| 128 | T-helper 1 type immune response (GO:0042088) | 2.80995146 |
| 129 | leukocyte mediated cytotoxicity (GO:0001909) | 2.80353286 |
| 130 | negative regulation of interleukin-12 production (GO:0032695) | 2.80300516 |
| 131 | * myeloid leukocyte activation (GO:0002274) | 2.78551259 |
| 132 | positive regulation of T cell apoptotic process (GO:0070234) | 2.76757716 |
| 133 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.75351880 |
| 134 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.74213765 |
| 135 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.73625530 |
| 136 | type I interferon signaling pathway (GO:0060337) | 2.72675732 |
| 137 | cellular response to type I interferon (GO:0071357) | 2.72675732 |
| 138 | phagosome maturation (GO:0090382) | 2.71890361 |
| 139 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.71823733 |
| 140 | positive regulation of chemokine production (GO:0032722) | 2.71745788 |
| 141 | response to type I interferon (GO:0034340) | 2.71034750 |
| 142 | negative regulation of granulocyte differentiation (GO:0030853) | 2.69307523 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.16744102 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.24819782 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.42466709 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.97429321 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.72671855 |
| 6 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 4.35683452 |
| 7 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.16897694 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.39808896 |
| 9 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.27398820 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.05382498 |
| 11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.02321328 |
| 12 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.62715343 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.58807098 |
| 14 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.54648371 |
| 15 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.54177132 |
| 16 | * FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.49044795 |
| 17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.45431254 |
| 18 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.40561078 |
| 19 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.34508268 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.32577059 |
| 21 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.32480282 |
| 22 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.22268264 |
| 23 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.16629610 |
| 24 | SPI1_23127762_ChIP-Seq_K562_Human | 2.12439662 |
| 25 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.97332865 |
| 26 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.94203648 |
| 27 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.86162613 |
| 28 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.80979111 |
| 29 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.79855041 |
| 30 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.77835633 |
| 31 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.76277002 |
| 32 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.73051981 |
| 33 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.71890249 |
| 34 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.71853408 |
| 35 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.71002532 |
| 36 | GATA1_22025678_ChIP-Seq_K562_Human | 1.70730512 |
| 37 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.68141977 |
| 38 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.65185872 |
| 39 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64211924 |
| 40 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.61831962 |
| 41 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.53391347 |
| 42 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.52833469 |
| 43 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.47891301 |
| 44 | MYB_26560356_Chip-Seq_TH2_Human | 1.46991837 |
| 45 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.45856715 |
| 46 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.44041598 |
| 47 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.42606977 |
| 48 | MAF_26560356_Chip-Seq_TH1_Human | 1.42187202 |
| 49 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.41466449 |
| 50 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.40412527 |
| 51 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40342553 |
| 52 | MYC_22102868_ChIP-Seq_BL_Human | 1.39495676 |
| 53 | MAF_26560356_Chip-Seq_TH2_Human | 1.35445990 |
| 54 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.31526330 |
| 55 | MYB_26560356_Chip-Seq_TH1_Human | 1.25404026 |
| 56 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.25345391 |
| 57 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20641157 |
| 58 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19730656 |
| 59 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19698448 |
| 60 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.17282439 |
| 61 | GATA3_26560356_Chip-Seq_TH2_Human | 1.15216234 |
| 62 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.12844673 |
| 63 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.12500634 |
| 64 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11496770 |
| 65 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.10453976 |
| 66 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.09080061 |
| 67 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.08926894 |
| 68 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.08849560 |
| 69 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04594156 |
| 70 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.04202611 |
| 71 | UTX_26944678_Chip-Seq_JUKART_Human | 1.04016360 |
| 72 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.02979060 |
| 73 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00581031 |
| 74 | GATA1_19941826_ChIP-Seq_K562_Human | 0.99181860 |
| 75 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.99098480 |
| 76 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.98588504 |
| 77 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.98059632 |
| 78 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.97314323 |
| 79 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97160910 |
| 80 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.96694810 |
| 81 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.96372284 |
| 82 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.94045831 |
| 83 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.92928721 |
| 84 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.92466230 |
| 85 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.91009878 |
| 86 | GATA2_19941826_ChIP-Seq_K562_Human | 0.90862355 |
| 87 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.89553473 |
| 88 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.89276727 |
| 89 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.89115502 |
| 90 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86451408 |
| 91 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.85995416 |
| 92 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.84110195 |
| 93 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.83998422 |
| 94 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.83567566 |
| 95 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.80644793 |
| 96 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.80404649 |
| 97 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.80404649 |
| 98 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80305169 |
| 99 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.80184577 |
| 100 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79292126 |
| 101 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.79225249 |
| 102 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.78751137 |
| 103 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.77134003 |
| 104 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.75177909 |
| 105 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.75017063 |
| 106 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.74809745 |
| 107 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.74286147 |
| 108 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.73860117 |
| 109 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.73779889 |
| 110 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.73371799 |
| 111 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73277175 |
| 112 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.72593184 |
| 113 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.72017044 |
| 114 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.71492242 |
| 115 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.70735539 |
| 116 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.70701000 |
| 117 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.70467946 |
| 118 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.66661434 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 4.92835028 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.96151716 |
| 3 | MP0003303_peritoneal_inflammation | 3.90730612 |
| 4 | MP0003436_decreased_susceptibility_to | 3.75136856 |
| 5 | MP0003172_abnormal_lysosome_physiology | 3.25513491 |
| 6 | MP0002419_abnormal_innate_immunity | 3.25329385 |
| 7 | MP0006082_CNS_inflammation | 3.19075363 |
| 8 | MP0009840_abnormal_foam_cell | 2.85531890 |
| 9 | MP0000569_abnormal_digit_pigmentation | 2.75888519 |
| 10 | * MP0005000_abnormal_immune_tolerance | 2.67521050 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.59342618 |
| 12 | MP0009785_altered_susceptibility_to | 2.58789580 |
| 13 | MP0002148_abnormal_hypersensitivity_rea | 2.47757345 |
| 14 | MP0005025_abnormal_response_to | 2.46654442 |
| 15 | MP0005387_immune_system_phenotype | 2.44299563 |
| 16 | MP0001790_abnormal_immune_system | 2.44299563 |
| 17 | MP0003724_increased_susceptibility_to | 2.40883918 |
| 18 | * MP0002452_abnormal_antigen_presenting | 2.38012913 |
| 19 | MP0003690_abnormal_glial_cell | 2.25070145 |
| 20 | MP0000604_amyloidosis | 2.24133515 |
| 21 | MP0004510_myositis | 2.14803978 |
| 22 | MP0001533_abnormal_skeleton_physiology | 2.11088445 |
| 23 | * MP0002723_abnormal_immune_serum | 2.08959682 |
| 24 | * MP0001800_abnormal_humoral_immune | 2.08744612 |
| 25 | MP0003300_gastrointestinal_ulcer | 2.08020995 |
| 26 | MP0005464_abnormal_platelet_physiology | 2.02437220 |
| 27 | MP0005451_abnormal_body_composition | 2.01303771 |
| 28 | MP0000685_abnormal_immune_system | 1.91802242 |
| 29 | * MP0001819_abnormal_immune_cell | 1.89295714 |
| 30 | * MP0002420_abnormal_adaptive_immunity | 1.87336507 |
| 31 | MP0003183_abnormal_peptide_metabolism | 1.77200959 |
| 32 | MP0003075_altered_response_to | 1.76222037 |
| 33 | MP0009278_abnormal_bone_marrow | 1.74214216 |
| 34 | MP0000343_altered_response_to | 1.73428367 |
| 35 | MP0003448_altered_tumor_morphology | 1.72419986 |
| 36 | MP0002405_respiratory_system_inflammati | 1.71703018 |
| 37 | MP0005310_abnormal_salivary_gland | 1.67089154 |
| 38 | MP0003763_abnormal_thymus_physiology | 1.64903970 |
| 39 | * MP0001845_abnormal_inflammatory_respons | 1.64677482 |
| 40 | MP0005671_abnormal_response_to | 1.64334171 |
| 41 | MP0004947_skin_inflammation | 1.58024592 |
| 42 | * MP0008469_abnormal_protein_level | 1.57222945 |
| 43 | MP0002132_abnormal_respiratory_system | 1.54015304 |
| 44 | MP0009764_decreased_sensitivity_to | 1.46417958 |
| 45 | MP0005166_decreased_susceptibility_to | 1.42122642 |
| 46 | MP0010307_abnormal_tumor_latency | 1.41643911 |
| 47 | MP0002998_abnormal_bone_remodeling | 1.41481761 |
| 48 | MP0001853_heart_inflammation | 1.40545743 |
| 49 | MP0003566_abnormal_cell_adhesion | 1.35743914 |
| 50 | MP0003705_abnormal_hypodermis_morpholog | 1.35738439 |
| 51 | MP0005174_abnormal_tail_pigmentation | 1.31379275 |
| 52 | MP0000465_gastrointestinal_hemorrhage | 1.31131250 |
| 53 | * MP0000716_abnormal_immune_system | 1.30581690 |
| 54 | MP0005167_abnormal_blood-brain_barrier | 1.30459087 |
| 55 | MP0003866_abnormal_defecation | 1.29295370 |
| 56 | MP0001851_eye_inflammation | 1.27000905 |
| 57 | MP0008438_abnormal_cutaneous_collagen | 1.26997236 |
| 58 | MP0005257_abnormal_intraocular_pressure | 1.25350765 |
| 59 | * MP0000689_abnormal_spleen_morphology | 1.23029697 |
| 60 | MP0010155_abnormal_intestine_physiology | 1.21213513 |
| 61 | MP0004381_abnormal_hair_follicle | 1.19975774 |
| 62 | MP0000858_altered_metastatic_potential | 1.19753782 |
| 63 | MP0005083_abnormal_biliary_tract | 1.19288802 |
| 64 | MP0005397_hematopoietic_system_phenotyp | 1.18134961 |
| 65 | MP0001545_abnormal_hematopoietic_system | 1.18134961 |
| 66 | MP0008004_abnormal_stomach_pH | 1.16394951 |
| 67 | MP0002398_abnormal_bone_marrow | 1.14318121 |
| 68 | MP0003828_pulmonary_edema | 1.13726822 |
| 69 | MP0003656_abnormal_erythrocyte_physiolo | 1.11187170 |
| 70 | MP0000703_abnormal_thymus_morphology | 1.11091059 |
| 71 | MP0002166_altered_tumor_susceptibility | 1.06380794 |
| 72 | MP0004130_abnormal_muscle_cell | 1.04959168 |
| 73 | * MP0002429_abnormal_blood_cell | 1.04820857 |
| 74 | MP0001958_emphysema | 1.03507704 |
| 75 | MP0005076_abnormal_cell_differentiation | 1.01473707 |
| 76 | MP0009763_increased_sensitivity_to | 0.99434357 |
| 77 | MP0002090_abnormal_vision | 0.97858320 |
| 78 | MP0005390_skeleton_phenotype | 0.96503023 |
| 79 | * MP0002722_abnormal_immune_system | 0.95649058 |
| 80 | MP0002396_abnormal_hematopoietic_system | 0.95291819 |
| 81 | MP0002277_abnormal_respiratory_mucosa | 0.95200665 |
| 82 | MP0002006_tumorigenesis | 0.94846086 |
| 83 | MP0009333_abnormal_splenocyte_physiolog | 0.91984598 |
| 84 | MP0002933_joint_inflammation | 0.91164162 |
| 85 | MP0005164_abnormal_response_to | 0.91020803 |
| 86 | MP0002332_abnormal_exercise_endurance | 0.89416807 |
| 87 | MP0002254_reproductive_system_inflammat | 0.89088787 |
| 88 | MP0004782_abnormal_surfactant_physiolog | 0.88564069 |
| 89 | MP0003221_abnormal_cardiomyocyte_apopto | 0.85193054 |
| 90 | MP0000920_abnormal_myelination | 0.82476907 |
| 91 | MP0008260_abnormal_autophagy | 0.81407583 |
| 92 | MP0010386_abnormal_urinary_bladder | 0.80199046 |
| 93 | MP0000015_abnormal_ear_pigmentation | 0.77873442 |
| 94 | MP0000249_abnormal_blood_vessel | 0.76811979 |
| 95 | MP0000609_abnormal_liver_physiology | 0.76557453 |
| 96 | MP0006054_spinal_hemorrhage | 0.76242002 |
| 97 | MP0009765_abnormal_xenobiotic_induced | 0.74288595 |
| 98 | MP0003795_abnormal_bone_structure | 0.73998864 |
| 99 | MP0010329_abnormal_lipoprotein_level | 0.73915560 |
| 100 | MP0003806_abnormal_nucleotide_metabolis | 0.70939374 |
| 101 | MP0008874_decreased_physiological_sensi | 0.70842563 |
| 102 | MP0003091_abnormal_cell_migration | 0.70107449 |
| 103 | MP0004883_abnormal_blood_vessel | 0.69060646 |
| 104 | MP0003045_fibrosis | 0.67332278 |
| 105 | MP0000767_abnormal_smooth_muscle | 0.67163320 |
| 106 | MP0000371_diluted_coat_color | 0.67026415 |
| 107 | MP0001873_stomach_inflammation | 0.65670914 |
| 108 | MP0003329_amyloid_beta_deposits | 0.64588418 |
| 109 | MP0005075_abnormal_melanosome_morpholog | 0.63467747 |
| 110 | MP0000598_abnormal_liver_morphology | 0.59350318 |
| 111 | MP0003195_calcinosis | 0.58775520 |
| 112 | MP0003634_abnormal_glial_cell | 0.58762581 |
| 113 | * MP0002136_abnormal_kidney_physiology | 0.58668786 |
| 114 | MP0003453_abnormal_keratinocyte_physiol | 0.57605588 |
| 115 | MP0004808_abnormal_hematopoietic_stem | 0.57341218 |
| 116 | MP0005319_abnormal_enzyme/_coenzyme | 0.56836015 |
| 117 | MP0003186_abnormal_redox_activity | 0.56707287 |
| 118 | MP0001663_abnormal_digestive_system | 0.56481345 |
| 119 | MP0004484_altered_response_of | 0.55635108 |
| 120 | MP0005376_homeostasis/metabolism_phenot | 0.53157157 |
| 121 | MP0002133_abnormal_respiratory_system | 0.48871888 |
| 122 | MP0005388_respiratory_system_phenotype | 0.48871888 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.94803768 |
| 2 | Increased cerebral lipofuscin (HP:0011813) | 6.61499036 |
| 3 | Vacuolated lymphocytes (HP:0001922) | 6.27457284 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 6.14270995 |
| 5 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.87546819 |
| 6 | Eczematoid dermatitis (HP:0000976) | 5.82695489 |
| 7 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 5.40432002 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 5.27914465 |
| 9 | Abnormality of macrophages (HP:0004311) | 5.17252469 |
| 10 | Dysostosis multiplex (HP:0000943) | 4.77065970 |
| 11 | Abnormality of glycolipid metabolism (HP:0010969) | 4.63815589 |
| 12 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.63815589 |
| 13 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.63815589 |
| 14 | Gastrointestinal infarctions (HP:0005244) | 4.46570647 |
| 15 | Disinhibition (HP:0000734) | 4.44197466 |
| 16 | Keratoconjunctivitis sicca (HP:0001097) | 4.21319596 |
| 17 | Axonal loss (HP:0003447) | 4.10126002 |
| 18 | Keratoconjunctivitis (HP:0001096) | 3.87628899 |
| 19 | Mucopolysacchariduria (HP:0008155) | 3.81893309 |
| 20 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.81893309 |
| 21 | Gingivitis (HP:0000230) | 3.77181100 |
| 22 | Glomerulonephritis (HP:0000099) | 3.69416678 |
| 23 | Loss of speech (HP:0002371) | 3.68583201 |
| 24 | Recurrent skin infections (HP:0001581) | 3.67500595 |
| 25 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.65539068 |
| 26 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.65539068 |
| 27 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.65539068 |
| 28 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.57202149 |
| 29 | Encephalitis (HP:0002383) | 3.55315570 |
| 30 | Autoimmune thrombocytopenia (HP:0001973) | 3.53130741 |
| 31 | T lymphocytopenia (HP:0005403) | 3.52392037 |
| 32 | Mediastinal lymphadenopathy (HP:0100721) | 3.51674083 |
| 33 | Myocardial infarction (HP:0001658) | 3.40031306 |
| 34 | Prostate neoplasm (HP:0100787) | 3.39367083 |
| 35 | Chronic obstructive pulmonary disease (HP:0006510) | 3.37741712 |
| 36 | Obstructive lung disease (HP:0006536) | 3.37741712 |
| 37 | Myositis (HP:0100614) | 3.35201763 |
| 38 | Hemoptysis (HP:0002105) | 3.34782130 |
| 39 | Abnormality of T cell number (HP:0011839) | 3.33972785 |
| 40 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.30760572 |
| 41 | Orchitis (HP:0100796) | 3.30075224 |
| 42 | Peritonitis (HP:0002586) | 3.13748113 |
| 43 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.13507922 |
| 44 | Agnosia (HP:0010524) | 3.10389477 |
| 45 | Chest pain (HP:0100749) | 3.09958684 |
| 46 | Recurrent fungal infections (HP:0002841) | 2.99812573 |
| 47 | Upper motor neuron abnormality (HP:0002127) | 2.98743419 |
| 48 | Periodontitis (HP:0000704) | 2.93785678 |
| 49 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.93234016 |
| 50 | Optic neuritis (HP:0100653) | 2.89238853 |
| 51 | Retrobulbar optic neuritis (HP:0100654) | 2.89238853 |
| 52 | Anorexia (HP:0002039) | 2.87580158 |
| 53 | Hepatosplenomegaly (HP:0001433) | 2.86962577 |
| 54 | Increased IgE level (HP:0003212) | 2.84895471 |
| 55 | Episodic fever (HP:0001954) | 2.82827770 |
| 56 | Hematochezia (HP:0002573) | 2.78066486 |
| 57 | Gangrene (HP:0100758) | 2.75997359 |
| 58 | Pulmonary embolism (HP:0002204) | 2.75805791 |
| 59 | Prolonged bleeding time (HP:0003010) | 2.72168331 |
| 60 | Thick nail (HP:0001805) | 2.71074218 |
| 61 | Complement deficiency (HP:0004431) | 2.65370905 |
| 62 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.62068139 |
| 63 | Pustule (HP:0200039) | 2.61262078 |
| 64 | Abnormality of complement system (HP:0005339) | 2.59542560 |
| 65 | Abnormality of the lumbar spine (HP:0100712) | 2.57532182 |
| 66 | Basal ganglia calcification (HP:0002135) | 2.56952790 |
| 67 | Urticaria (HP:0001025) | 2.56545084 |
| 68 | J-shaped sella turcica (HP:0002680) | 2.55497845 |
| 69 | Epistaxis (HP:0000421) | 2.53948126 |
| 70 | Stomatitis (HP:0010280) | 2.53276095 |
| 71 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.52449869 |
| 72 | Cellulitis (HP:0100658) | 2.50607114 |
| 73 | Increased IgM level (HP:0003496) | 2.49610354 |
| 74 | Recurrent viral infections (HP:0004429) | 2.49449222 |
| 75 | Nephritis (HP:0000123) | 2.48747271 |
| 76 | Abnormality of T cells (HP:0002843) | 2.47068270 |
| 77 | Peripheral demyelination (HP:0011096) | 2.46537588 |
| 78 | Spontaneous hematomas (HP:0007420) | 2.46296367 |
| 79 | Thoracic kyphosis (HP:0002942) | 2.44844490 |
| 80 | Joint hemorrhage (HP:0005261) | 2.43939171 |
| 81 | Pathologic fracture (HP:0002756) | 2.41532582 |
| 82 | Abnormality of the pleura (HP:0002103) | 2.38098021 |
| 83 | Inappropriate behavior (HP:0000719) | 2.35915844 |
| 84 | Conjunctival telangiectasia (HP:0000524) | 2.35630447 |
| 85 | Abnormality of the endocardium (HP:0004306) | 2.35299520 |
| 86 | Diminished motivation (HP:0000745) | 2.34134661 |
| 87 | Vasculitis (HP:0002633) | 2.33722443 |
| 88 | Apathy (HP:0000741) | 2.33176284 |
| 89 | Neuronal loss in central nervous system (HP:0002529) | 2.32544332 |
| 90 | Abnormality of the peritoneum (HP:0002585) | 2.30033805 |
| 91 | Asymmetric septal hypertrophy (HP:0001670) | 2.29630254 |
| 92 | Gastrointestinal inflammation (HP:0004386) | 2.25610378 |
| 93 | Increased CSF protein (HP:0002922) | 2.24997357 |
| 94 | Osteolytic defects of the hand bones (HP:0009699) | 2.24515940 |
| 95 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.24515940 |
| 96 | Vertigo (HP:0002321) | 2.24194881 |
| 97 | Osteomyelitis (HP:0002754) | 2.22521966 |
| 98 | Hypochromic microcytic anemia (HP:0004840) | 2.22079213 |
| 99 | Global brain atrophy (HP:0002283) | 2.21117501 |
| 100 | Granulocytopenia (HP:0001913) | 2.18304822 |
| 101 | Glomerulopathy (HP:0100820) | 2.16424565 |
| 102 | Hypochromic anemia (HP:0001931) | 2.14310256 |
| 103 | Sepsis (HP:0100806) | 2.14284976 |
| 104 | Hypercholesterolemia (HP:0003124) | 2.13925191 |
| 105 | Petechiae (HP:0000967) | 2.11983443 |
| 106 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.09835601 |
| 107 | Recurrent cutaneous fungal infections (HP:0011370) | 2.09835601 |
| 108 | Interstitial pulmonary disease (HP:0006530) | 2.09829398 |
| 109 | Progressive visual loss (HP:0000529) | 2.08088207 |
| 110 | Polyneuropathy (HP:0001271) | 2.07665523 |
| 111 | Mutism (HP:0002300) | 2.07202801 |
| 112 | Keratitis (HP:0000491) | 2.06887799 |
| 113 | Acne (HP:0001061) | 2.06685394 |
| 114 | Arterial thrombosis (HP:0004420) | 2.06189396 |
| 115 | Amaurosis fugax (HP:0100576) | 2.05862258 |
| 116 | Hypergammaglobulinemia (HP:0010702) | 2.05031597 |
| 117 | Slow saccadic eye movements (HP:0000514) | 2.04902688 |
| 118 | Personality changes (HP:0000751) | 2.02725378 |
| 119 | Gingival bleeding (HP:0000225) | 2.02480215 |
| 120 | Purpura (HP:0000979) | 2.02425620 |
| 121 | Eosinophilia (HP:0001880) | 2.02204352 |
| 122 | Colitis (HP:0002583) | 1.98223635 |
| 123 | Increased serum ferritin (HP:0003281) | 1.98179983 |
| 124 | Retinal atrophy (HP:0001105) | 1.98138917 |
| 125 | Bone pain (HP:0002653) | 1.97549551 |
| 126 | Esophageal varix (HP:0002040) | 1.96559737 |
| 127 | Leukocytosis (HP:0001974) | 1.96361489 |
| 128 | Pulmonary infiltrates (HP:0002113) | 1.95678074 |
| 129 | Recurrent pneumonia (HP:0006532) | 1.95439782 |
| 130 | Subacute progressive viral hepatitis (HP:0006572) | 1.94945566 |
| 131 | Meningitis (HP:0001287) | 1.93166542 |
| 132 | Abnormality of the thoracic spine (HP:0100711) | 1.93142903 |
| 133 | Tetraparesis (HP:0002273) | 1.91278918 |
| 134 | Skin ulcer (HP:0200042) | 1.90651217 |
| 135 | Cheilitis (HP:0100825) | 1.89531767 |
| 136 | Viral hepatitis (HP:0006562) | 1.89191827 |
| 137 | Abnormality of the pericardium (HP:0001697) | 1.88072191 |
| 138 | Abnormality of the prostate (HP:0008775) | 1.87755508 |
| 139 | Deformed sella turcica (HP:0002681) | 1.87411325 |
| 140 | Inflammation of the large intestine (HP:0002037) | 1.86718513 |
| 141 | Thrombophlebitis (HP:0004418) | 1.86644203 |
| 142 | Panhypogammaglobulinemia (HP:0003139) | 1.85348913 |
| 143 | Acute hepatic failure (HP:0006554) | 1.84364910 |
| 144 | Lymphopenia (HP:0001888) | 1.84356349 |
| 145 | Neurofibrillary tangles (HP:0002185) | 1.83477199 |
| 146 | Microcytic anemia (HP:0001935) | 1.82801522 |
| 147 | Supranuclear gaze palsy (HP:0000605) | 1.80595328 |
| 148 | Chronic otitis media (HP:0000389) | 1.80557431 |
| 149 | Amyloidosis (HP:0011034) | 1.74870754 |
| 150 | Premature loss of primary teeth (HP:0006323) | 1.74719491 |
| 151 | Spondylolisthesis (HP:0003302) | 1.72018172 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.03235718 |
| 2 | BLK | 3.88456416 |
| 3 | TYK2 | 3.44964938 |
| 4 | KIT | 3.17464028 |
| 5 | IRAK4 | 2.96346896 |
| 6 | TBK1 | 2.83745080 |
| 7 | ERN1 | 2.81486642 |
| 8 | MAP4K1 | 2.57857443 |
| 9 | MAP3K14 | 2.37104900 |
| 10 | TGFBR2 | 2.28182471 |
| 11 | PRPF4B | 2.20144044 |
| 12 | IRAK3 | 2.10131996 |
| 13 | TAOK3 | 2.07845682 |
| 14 | JAK1 | 2.06203325 |
| 15 | CAMK1D | 2.05689016 |
| 16 | CSK | 1.97883274 |
| 17 | RIPK1 | 1.93656920 |
| 18 | CSF1R | 1.89761415 |
| 19 | FGR | 1.89241845 |
| 20 | IKBKE | 1.86612456 |
| 21 | FES | 1.81619919 |
| 22 | HCK | 1.64557612 |
| 23 | TAOK1 | 1.61868909 |
| 24 | TRIB3 | 1.61491791 |
| 25 | TTN | 1.59691356 |
| 26 | MAP2K3 | 1.57863268 |
| 27 | TNK2 | 1.56592612 |
| 28 | SCYL2 | 1.56578683 |
| 29 | JAK3 | 1.53011399 |
| 30 | IKBKB | 1.52373370 |
| 31 | PBK | 1.52311138 |
| 32 | MAP3K13 | 1.46723748 |
| 33 | EPHB1 | 1.45286981 |
| 34 | CAMK1G | 1.38867978 |
| 35 | IRAK1 | 1.37369098 |
| 36 | NEK9 | 1.36861874 |
| 37 | JAK2 | 1.35758740 |
| 38 | ZAP70 | 1.35708004 |
| 39 | SYK | 1.35583817 |
| 40 | IRAK2 | 1.25650801 |
| 41 | STK10 | 1.22239313 |
| 42 | LYN | 1.21288238 |
| 43 | MATK | 1.18132366 |
| 44 | CAMKK2 | 1.16185324 |
| 45 | BTK | 1.11334800 |
| 46 | PKN2 | 1.08688621 |
| 47 | LCK | 1.08384245 |
| 48 | MAP3K6 | 1.06990849 |
| 49 | TRPM7 | 0.98891432 |
| 50 | MAP3K3 | 0.96359832 |
| 51 | MARK3 | 0.96326221 |
| 52 | TAOK2 | 0.95640705 |
| 53 | SIK3 | 0.94241007 |
| 54 | TEC | 0.92466183 |
| 55 | PTK6 | 0.91114993 |
| 56 | EGFR | 0.89923402 |
| 57 | RPS6KA4 | 0.89215442 |
| 58 | GRK7 | 0.88843521 |
| 59 | MARK2 | 0.86317773 |
| 60 | TXK | 0.86285970 |
| 61 | PIM2 | 0.85224737 |
| 62 | ABL2 | 0.84032698 |
| 63 | PAK4 | 0.81461355 |
| 64 | LRRK2 | 0.79552750 |
| 65 | CDK6 | 0.77627563 |
| 66 | FGFR3 | 0.76829047 |
| 67 | ITK | 0.76746757 |
| 68 | KSR2 | 0.75446099 |
| 69 | GRK6 | 0.74868762 |
| 70 | CAMKK1 | 0.74784788 |
| 71 | SIK2 | 0.74294832 |
| 72 | NME2 | 0.72826599 |
| 73 | CLK1 | 0.71871440 |
| 74 | PRKCD | 0.71343019 |
| 75 | EPHA3 | 0.70883352 |
| 76 | ABL1 | 0.69942724 |
| 77 | CDC42BPA | 0.69203930 |
| 78 | PIM1 | 0.68879826 |
| 79 | MAP3K2 | 0.68544884 |
| 80 | MAP2K4 | 0.67294127 |
| 81 | CHUK | 0.67228944 |
| 82 | MAP3K11 | 0.64654382 |
| 83 | FYN | 0.64171067 |
| 84 | FGFR4 | 0.63258959 |
| 85 | KSR1 | 0.63119642 |
| 86 | STK4 | 0.62887189 |
| 87 | MAP3K5 | 0.58605651 |
| 88 | DAPK2 | 0.57916405 |
| 89 | RAF1 | 0.57326900 |
| 90 | MOS | 0.55843723 |
| 91 | PTK2B | 0.55640479 |
| 92 | PDPK1 | 0.55405982 |
| 93 | DYRK1B | 0.55210027 |
| 94 | BMX | 0.55022528 |
| 95 | MAP2K6 | 0.51658778 |
| 96 | CDK19 | 0.50184167 |
| 97 | STK3 | 0.49629348 |
| 98 | PDK1 | 0.49244942 |
| 99 | SGK2 | 0.48987831 |
| 100 | STK11 | 0.48562055 |
| 101 | PRKD2 | 0.48559945 |
| 102 | NLK | 0.48177176 |
| 103 | DYRK3 | 0.47505257 |
| 104 | PRKCH | 0.44674673 |
| 105 | HIPK2 | 0.44347763 |
| 106 | WNK1 | 0.43708591 |
| 107 | MAPK7 | 0.43378454 |
| 108 | RET | 0.43203058 |
| 109 | CDK12 | 0.41075035 |
| 110 | ACVR1B | 0.40973472 |
| 111 | MAPK12 | 0.40203561 |
| 112 | YES1 | 0.39943635 |
| 113 | ERBB3 | 0.39722578 |
| 114 | DMPK | 0.39141145 |
| 115 | RPS6KL1 | 0.37945905 |
| 116 | RPS6KC1 | 0.37945905 |
| 117 | SGK3 | 0.37616404 |
| 118 | IGF1R | 0.36102190 |
| 119 | PRKCQ | 0.35617595 |
| 120 | MAP3K7 | 0.35183397 |
| 121 | MAPKAPK2 | 0.34563458 |
| 122 | PDGFRB | 0.34440579 |
| 123 | MAP3K1 | 0.34142210 |
| 124 | BMPR2 | 0.32185830 |
| 125 | RPS6KA6 | 0.31083233 |
| 126 | PIK3CG | 0.28867874 |
| 127 | GSK3A | 0.28219169 |
| 128 | TESK1 | 0.27418955 |
| 129 | SRC | 0.26642927 |
| 130 | CDK9 | 0.26590329 |
| 131 | TESK2 | 0.26024397 |
| 132 | DAPK3 | 0.25509298 |
| 133 | KDR | 0.24319356 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.33963066 |
| 2 | Lysosome_Homo sapiens_hsa04142 | 3.64051471 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.63400894 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 3.25243931 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.75380471 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.64273633 |
| 7 | Tuberculosis_Homo sapiens_hsa05152 | 2.55281734 |
| 8 | Phagosome_Homo sapiens_hsa04145 | 2.54611503 |
| 9 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.42543531 |
| 10 | Pertussis_Homo sapiens_hsa05133 | 2.30654038 |
| 11 | Malaria_Homo sapiens_hsa05144 | 2.20463277 |
| 12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.01089442 |
| 13 | Legionellosis_Homo sapiens_hsa05134 | 1.92263421 |
| 14 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.89111094 |
| 15 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.87256948 |
| 16 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.82709930 |
| 17 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.81622656 |
| 18 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.74740745 |
| 19 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.70516671 |
| 20 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.67995781 |
| 21 | Measles_Homo sapiens_hsa05162 | 1.66951569 |
| 22 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.50707406 |
| 23 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.50510534 |
| 24 | Influenza A_Homo sapiens_hsa05164 | 1.49530877 |
| 25 | Salmonella infection_Homo sapiens_hsa05132 | 1.48468385 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.46304716 |
| 27 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.46225021 |
| 28 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.41271488 |
| 29 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.37844575 |
| 30 | Shigellosis_Homo sapiens_hsa05131 | 1.34215991 |
| 31 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.32997306 |
| 32 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.26438822 |
| 33 | Apoptosis_Homo sapiens_hsa04210 | 1.25030450 |
| 34 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.24535022 |
| 35 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.23159332 |
| 36 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.22388570 |
| 37 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.20234791 |
| 38 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.10627489 |
| 39 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.10446361 |
| 40 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.10105970 |
| 41 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.09003393 |
| 42 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.08898048 |
| 43 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.08829307 |
| 44 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.05710265 |
| 45 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.03470334 |
| 46 | Asthma_Homo sapiens_hsa05310 | 1.03365524 |
| 47 | Hepatitis B_Homo sapiens_hsa05161 | 1.00817075 |
| 48 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.97863275 |
| 49 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.97783005 |
| 50 | Hepatitis C_Homo sapiens_hsa05160 | 0.95822248 |
| 51 | Amoebiasis_Homo sapiens_hsa05146 | 0.93569728 |
| 52 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.92881217 |
| 53 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.90072434 |
| 54 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.88193626 |
| 55 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.83696404 |
| 56 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.78774846 |
| 57 | Endocytosis_Homo sapiens_hsa04144 | 0.75383765 |
| 58 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.74592635 |
| 59 | Platelet activation_Homo sapiens_hsa04611 | 0.74419944 |
| 60 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.74068698 |
| 61 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.73674662 |
| 62 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.73488376 |
| 63 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.72855619 |
| 64 | Viral myocarditis_Homo sapiens_hsa05416 | 0.72600687 |
| 65 | Allograft rejection_Homo sapiens_hsa05330 | 0.71870926 |
| 66 | Prion diseases_Homo sapiens_hsa05020 | 0.71731333 |
| 67 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.69458627 |
| 68 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.69234286 |
| 69 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.67287254 |
| 70 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.66310428 |
| 71 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.65079812 |
| 72 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.64629694 |
| 73 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.61604269 |
| 74 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.60549349 |
| 75 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.58508194 |
| 76 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.58368015 |
| 77 | Endometrial cancer_Homo sapiens_hsa05213 | 0.55502174 |
| 78 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.55360044 |
| 79 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.55308623 |
| 80 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.52950757 |
| 81 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.49163844 |
| 82 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.45537351 |
| 83 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.44806499 |
| 84 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44468140 |
| 85 | Mineral absorption_Homo sapiens_hsa04978 | 0.42598277 |
| 86 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.42573728 |
| 87 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.41896581 |
| 88 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.41769216 |
| 89 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.40845661 |
| 90 | HTLV-I infection_Homo sapiens_hsa05166 | 0.40594378 |
| 91 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.39275055 |
| 92 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.39116635 |
| 93 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.38079270 |
| 94 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.37761466 |
| 95 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.37477765 |
| 96 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.37471714 |
| 97 | ABC transporters_Homo sapiens_hsa02010 | 0.36474038 |
| 98 | Insulin resistance_Homo sapiens_hsa04931 | 0.36257247 |
| 99 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.33756319 |
| 100 | Prostate cancer_Homo sapiens_hsa05215 | 0.33562063 |
| 101 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.32588305 |
| 102 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.32071293 |
| 103 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.31740348 |
| 104 | Colorectal cancer_Homo sapiens_hsa05210 | 0.31170502 |
| 105 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.30480869 |
| 106 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.29204005 |
| 107 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.28905129 |
| 108 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.27386798 |
| 109 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.26932649 |
| 110 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.26744194 |
| 111 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.26247729 |
| 112 | Histidine metabolism_Homo sapiens_hsa00340 | 0.26044387 |
| 113 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.25580536 |
| 114 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.24924151 |
| 115 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.24066112 |
| 116 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.22391789 |
| 117 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.21448115 |
| 118 | Focal adhesion_Homo sapiens_hsa04510 | 0.20211706 |
| 119 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.20085583 |
| 120 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.19395774 |
| 121 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.18822690 |

